Analog Devices, Inc. (ADI) is in a strong recovery and reacceleration phase after a cyclical revenue trough in fiscal 2024. The company designs and sells high-performance analog, mixed-signal, and digital signal processing chips — the kind of precision components that sit at the heart of industrial automation, automotive systems, communications infrastructure, and healthcare equipment. After revenues dipped sharply from their fiscal 2023 peak, ADI has bounced back with improving top-line growth and, critically, dramatically expanding margins. Its most recent quarterly results (through August 2026) show gross margins near 67% and operating margins above 40% — among the best in the semiconductor industry — while the balance sheet remains conservatively levered. Capital expenditure intensity has also been falling, suggesting the heavy investment cycle is behind the company and free cash flow generation is improving. The long-term five-year revenue CAGR of approximately 14.5% speaks to ADI's durable compounding ability, even if a near-term cyclical downturn dragged the three-year CAGR into slightly negative territory.
Snapshot & Big Picture
ADI operates in the analog semiconductor space, a market characterized by high barriers to entry, long product life cycles, and sticky customer relationships. Its chips are found in factory automation systems, EV battery management, 5G base stations, and medical imaging devices, among many other applications. Because analog components are often deeply designed into a customer's end product, switching costs are high and pricing power is durable — a dynamic that shows up clearly in ADI's consistently high gross margins, which have ranged between roughly 60% and 68% over the past nine fiscal years.
The company's revenue story over this period is shaped by two major events: the transformative acquisition of Maxim Integrated in fiscal 2021, which roughly doubled ADI's revenue base, and the cyclical semiconductor inventory correction of 2023–2024, which pulled revenues back from their post-acquisition peak. Both dynamics are visible in the annual data below.
| Fiscal Year End | Revenue | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|---|
| Oct 2017 | $5.25B | 60.4% | 22.2% | 15.4% |
| Nov 2018 | $6.22B | 68.3% | 30.5% | 24.2% |
| Nov 2019 | $5.99B | 67.0% | 28.6% | 22.8% |
| Oct 2020 | $5.60B | 65.9% | 26.7% | 21.8% |
| Oct 2021 | $7.32B | 61.8% | 23.1% | 19.0% |
| Oct 2022 | $12.01B | 62.7% | 27.3% | 22.9% |
| Oct 2023 | $12.31B | 64.0% | 31.1% | 26.9% |
| Nov 2024 | $9.43B | 57.1% | 21.6% | 17.3% |
| Nov 2025 | $11.02B | 61.5% | 26.6% | 20.6% |
Latest Quarter Snapshot
The most recent quarterly data — for the quarter ending August 1, 2026, filed August 19, 2026 — is more current than the annual figures and paints a notably brighter picture. This quarter reflects ADI's recovery accelerating into fiscal 2026, with margins expanding well beyond what the full fiscal 2025 annual figures show.
| Metric | Q3 FY2026 (Period End Aug 1, 2026) |
|---|---|
| Revenue | $4.02B |
| EBITDA | $2.10B |
| Gross Margin | 67.3% |
| Operating Margin | 40.1% |
| Net Margin | 33.3% |
| Current Ratio | 1.25x |
| Debt-to-Equity | 0.24x |
| Capital Expenditures | $109.3M |
| CapEx / Revenue | 2.7% |
The operating margin of 40.1% in the most recent quarter is exceptional and reflects the high operating leverage inherent in ADI's business model: as revenue recovers, a large portion of incremental revenue flows through to operating income because the cost structure does not scale proportionally. Gross margin of 67.3% is also at the high end of ADI's historical range, suggesting favorable product mix and pricing discipline.
Profitability
ADI's profitability profile is one of its defining strengths. Gross margins have consistently held in the high-50% to high-60% range across all nine fiscal years of data, reflecting the company's pricing power in precision analog markets. The most notable exception was fiscal 2024, when the inventory correction drove revenue down sharply and gross margin compressed to 57.1% — the lowest in the dataset — as fixed manufacturing costs were spread over a smaller revenue base. The recovery in fiscal 2025 and the even stronger margins seen in the most recent quarter suggest this was cyclical compression rather than structural deterioration.
Operating margins tell a similar story. They ranged from the low-to-mid 20% range in periods of investment or cyclical weakness, and climbed as high as 31.1% at the fiscal 2023 peak. The current quarterly run rate of 40.1% operating margin — if sustained — would represent a meaningful step-change above prior cycle peaks, pointing to structural improvements in the business's cost efficiency as Maxim integration benefits continue to compound.
Net margins have generally tracked operating margins, ranging from roughly 15% to 27% on an annual basis. At 33.3% in the most recent quarter, net margins are similarly elevated, consistent with the operating leverage story.
Financial Health
ADI's balance sheet is conservatively managed. The debt-to-equity ratio for fiscal years prior to 2022 was not separately reported in the available data, but for fiscal years 2022 through 2025 and the most recent quarter it has remained low and stable — ranging from 0.18x to 0.24x — reflecting disciplined use of leverage even after a large acquisition. The current ratio has generally stayed above 1.3x across all periods, indicating adequate short-term liquidity, though it dipped to 1.25x in the most recent quarter, still a comfortable level.
Capital expenditure trends are particularly informative. After running at modest levels (roughly 3–5% of revenue) through fiscal 2017–2021, CapEx intensity spiked significantly following the Maxim acquisition — peaking at 10.3% of revenue in fiscal 2023 as ADI invested heavily in manufacturing capacity and integration. Since then, the trend has reversed sharply:
| Fiscal Year End | Capital Expenditures | CapEx / Revenue |
|---|---|---|
| Oct 2017 | $204.1M | 3.9% |
| Nov 2018 | $254.9M | 4.1% |
| Nov 2019 | $275.4M | 4.6% |
| Oct 2020 | $165.7M | 3.0% |
| Oct 2021 | $343.7M | 4.7% |
| Oct 2022 | $699.3M | 5.8% |
| Oct 2023 | $1,261.5M | 10.3% |
| Nov 2024 | $730.5M | 7.7% |
| Nov 2025 | $533.6M | 4.8% |
| Q3 FY2026 (Quarterly) | $109.3M | 2.7% |
The declining CapEx intensity — from a peak of 10.3% in fiscal 2023 down to 4.8% in fiscal 2025 and just 2.7% annualized in the most recent quarter — implies that ADI has moved past the heavy reinvestment phase associated with the Maxim integration. A lower capital intensity combined with expanding margins is a powerful combination for free cash flow generation, and this trend is a meaningful positive signal for shareholder returns capacity going forward.
Growth
ADI's revenue growth profile is shaped by cyclicality, acquisition, and end-market diversity. The CAGR figures below capture different phases of that story:
| Window | Start Fiscal Year | End Fiscal Year | Start Revenue | End Revenue | CAGR |
|---|---|---|---|---|---|
| 3-Year | Oct 2022 | Nov 2025 | $12.01B | $11.02B | -2.8% |
| 5-Year | Oct 2020 | Nov 2025 | $5.60B | $11.02B | +14.5% |
| 10-Year | N/A | N/A | N/A | N/A | Not available — ADI's SEC filing history in this dataset does not extend back a full ten fiscal years from the most recent period end, making a precise 10-year CAGR calculation unavailable. |
The negative three-year CAGR of -2.8% reflects the semiconductor cycle — ADI's revenue in fiscal 2022 was near its all-time peak, and the subsequent inventory correction pushed fiscal 2024 revenues well below that level. Measured from the more representative pre-Maxim fiscal 2020 base, the five-year CAGR of +14.5% tells a more complete story: ADI has nearly doubled its revenue over five years through a combination of strategic acquisition and organic growth in secular themes like industrial automation, EV adoption, and 5G infrastructure. With margins now recovering and CapEx intensity declining, the recovery trajectory into fiscal 2026 supports optimism that the three-year CAGR will improve materially as the cycle comparison base normalizes.

Leave a Comment